Larvol Delta - Agomab-Announces-Positive-Phase-1-Results-for-AGMB447-in-Patients-with-Idiopathic-Pulmonary-Fibrosis

AGMB-447 - AgomAb Therapeutics

https://www.globenewswire.com/news-release/2026/09/14/3361543/0/en/agomab-announces-positive-phase-1-results-for-agmb-447-in-patients-with-idiopathic-pulmonary-fibrosis-and-design-of-phase-2-inspiria-study.html

Sep 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next